Daratumumab for relapsed AL amyloidosis—When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review

Tamir Shragai, Moshe Gatt, Noa Lavie, Iuliana Vaxman, Tamar Tadmor, Ory Rouvio, Miri Zektser, Nethanel Horowitz, Hila Magen, Mouna Ballan, Celia Suru, Efrat Luttwak, Shai Levi, Tomer Ziv, Irit Avivi, Yael C. Cohen, Tomer Ziv-Baran

Tel Aviv University, Ben-Gurion University of the Negev, Technion - Israel Institute of Technology, The Hebrew University of Jerusalem

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Daratumumab for relapsed AL amyloidosis—When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review'. Together they form a unique fingerprint.

Medicine & Life Sciences